Molecular Testing in CML between Old and New Methods: Are We at a Turning Point?

chronic myeloid leukemia digital PCR next-generation sequencing tyrosine kinase inhibitors

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
27 Nov 2020
Historique:
received: 27 10 2020
revised: 20 11 2020
accepted: 25 11 2020
entrez: 2 12 2020
pubmed: 3 12 2020
medline: 3 12 2020
Statut: epublish

Résumé

Molecular monitoring of minimal residual disease (MRD) and

Identifiants

pubmed: 33261150
pii: jcm9123865
doi: 10.3390/jcm9123865
pmc: PMC7760306
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Références

Int J Mol Med. 2019 Dec;44(6):2133-2144
pubmed: 31638195
Blood Cancer J. 2015 Sep 18;5:e347
pubmed: 26383820
Genes Chromosomes Cancer. 2012 Nov;51(11):1045-53
pubmed: 22887688
Blood. 2013 Aug 8;122(6):872-84
pubmed: 23803709
Ann Lab Med. 2020 Jan;40(1):72-75
pubmed: 31432643
Eur J Haematol. 2019 Jul;103(1):26-34
pubmed: 30985947
Mol Cancer. 2018 Feb 19;17(1):49
pubmed: 29455643
Cancer Manag Res. 2020 May 06;12:3175-3189
pubmed: 32440215
Spectrochim Acta A Mol Biomol Spectrosc. 2013 Feb 15;103:325-32
pubmed: 23261630
Cancer Cell. 2014 Sep 8;26(3):428-442
pubmed: 25132497
Blood Adv. 2019 Dec 23;3(24):4280-4290
pubmed: 31869412
Leukemia. 2020 Apr;34(4):966-984
pubmed: 32127639
Leuk Res. 2018 Jun;69:89-93
pubmed: 29705537
J Mol Diagn. 2019 Jan;21(1):27-37
pubmed: 30347270
Leuk Lymphoma. 2011 May;52(5):896-904
pubmed: 21338281
BMC Cancer. 2016 Aug 02;16:572
pubmed: 27485109
Sci Rep. 2019 Dec 20;9(1):19606
pubmed: 31862911
J Mol Diagn. 2019 Jul;21(4):718-733
pubmed: 31026597
Methods Mol Biol. 2016;1392:43-50
pubmed: 26843045
Eur J Haematol. 2019 Sep;103(3):272-273
pubmed: 31233644
PLoS One. 2019 Mar 21;14(3):e0214305
pubmed: 30897165
Acta Haematol. 2020;143(5):509-510
pubmed: 31922494
Clin Cancer Res. 2019 Nov 15;25(22):6606-6613
pubmed: 31292142
Bull Cancer. 2020 Jan;107(1):113-128
pubmed: 31353136
Front Oncol. 2019 Sep 06;9:833
pubmed: 31555590
Oncotarget. 2018 Jan 5;9(13):10978-10986
pubmed: 29541390
Int J Mol Sci. 2020 Apr 29;21(9):
pubmed: 32365599
Cancers (Basel). 2020 Jun 30;12(7):
pubmed: 32629801
Anal Bioanal Chem. 2016 Feb;408(4):1079-94
pubmed: 26631023
J Cell Mol Med. 2016 Oct;20(10):1829-39
pubmed: 27196940
J Mol Diagn. 2020 Jan;22(1):81-89
pubmed: 31669230
Eur J Haematol. 2018 Sep;101(3):291-296
pubmed: 29691899
Case Rep Oncol. 2020 Oct 15;13(3):1263-1269
pubmed: 33250741
Cancers (Basel). 2023 Aug 15;15(16):
pubmed: 37627140
Leukemia. 2015 May;29(5):999-1003
pubmed: 25652737
Blood. 2013 Aug 29;122(9):1634-48
pubmed: 23794064
Blood. 2018 Aug 30;132(9):948-961
pubmed: 29967129
Exp Hematol. 2020 Jan;81:60-67
pubmed: 31931069
Front Pharmacol. 2016 Oct 13;7:363
pubmed: 27790140
Haematologica. 2016 Jul;101(7):830-8
pubmed: 27102501
J Cell Mol Med. 2019 Aug;23(8):4955-4961
pubmed: 31199062
Springerplus. 2016 May 10;5:569
pubmed: 27247866
Int J Mol Sci. 2019 May 07;20(9):
pubmed: 31067725
Cancer Med. 2019 May;8(5):2041-2055
pubmed: 30950237
Blood. 2011 Aug 4;118(5):1208-15
pubmed: 21562040
Hypoxia (Auckl). 2014 Jan 21;2:1-10
pubmed: 27774462
J Hematol Oncol. 2019 Dec 5;12(1):131
pubmed: 31801582
Blood Res. 2018 Mar;53(1):3-6
pubmed: 29662853
J Cancer Res Clin Oncol. 2015 May;141(5):887-99
pubmed: 25367136
Leukemia. 2019 Aug;33(8):1835-1850
pubmed: 31209280
Nat Med. 2017 Jun;23(6):692-702
pubmed: 28504724
PLoS One. 2019 Mar 5;14(3):e0207170
pubmed: 30835732
Int J Lab Hematol. 2015 Dec;37(6):766-73
pubmed: 26189968
Am J Hematol. 2015 Oct;90(10):910-4
pubmed: 26178642
Haematologica. 2018 Jun;103(6):1029-1037
pubmed: 29567768
Sensors (Basel). 2018 Apr 20;18(4):
pubmed: 29677144
Blood. 2020 Feb 20;135(8):534-541
pubmed: 31877211
N Engl J Med. 2003 Mar 13;348(11):994-1004
pubmed: 12637609
Clin Cancer Res. 2018 Nov 1;24(21):5321-5334
pubmed: 30042204
Leukemia. 2019 May;33(5):1173-1183
pubmed: 30675008
Methods Mol Biol. 2020;2065:153-173
pubmed: 31578694
Leuk Lymphoma. 2019 Oct;60(10):2384-2393
pubmed: 30912699
Exp Mol Pathol. 2017 Aug;103(1):33-37
pubmed: 28663031
J Clin Med. 2020 Jan 19;9(1):
pubmed: 31963812
Br J Haematol. 2017 May;177(4):588-596
pubmed: 28419517
Sci Rep. 2020 Sep 25;10(1):15745
pubmed: 32978468
Oncotarget. 2016 Apr 19;7(16):21982-90
pubmed: 26980736
Lancet Haematol. 2019 May;6(5):e276-e284
pubmed: 31036317
Leuk Lymphoma. 2019 Nov;60(11):2838-2840
pubmed: 31050551

Auteurs

Simona Soverini (S)

Department of Experimental, Diagnostic and Specialty Medicine, Hematology/Oncology "Lorenzo e Ariosto Seràgnoli", University of Bologna, 40138 Bologna, Italy.

Simona Bernardi (S)

Department of Clinical and Experimental Sciences, University of Brescia, Bone Marrow Transplant Unit, ASST Spedali Civili, 25123 Brescia, Italy.
Centro di Ricerca Emato-Oncologica AIL (CREA), ASST Spedali Civili, 25123 Brescia, Italy.

Sara Galimberti (S)

Department of Clinical and Experimental Medicine, Hematology Unit, University of Pisa, 56126 Pisa, Italy.

Classifications MeSH